Home > Insider Trading > Filing (0001764013-23-000155)

Filing Details

Accession Number:: 0001764013-23-000155
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-05 16:28:23
Reporting Period:: 2023-12-01

Accepted Time:: 2023-12-05 16:28:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1764013	Immunovant Inc.	IMVT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1643071	Atul Pande	320 W 37Th Street, 6Th Floor New York NY 10018		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2023-12-01	4,129	$38.80	91,379	No	4	S	Direct
Common Stock	Disposition	2023-12-01	3,374	$39.82	88,005	No	4	S	Direct
Common Stock	Disposition	2023-12-01	4,847	$40.46	83,158	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	20,000	Indirect	By Trust

Footnotes

Represents the sale of shares of common stock pursuant to a Rule 10b5-1 trading plan adopted on May 24, 2023, in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of the above award of restricted stock covering shares of common stock and does not represent a discretionary sale by the reporting person.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $38.20 - $39.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $39.21 - $40.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $40.23 - $40.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.